Avantor Welcomes Dame Louise Makin to Its Leadership
Avantor, Inc. (NYSE: AVTR), a prominent global provider of essential products and services for life sciences and advanced technology sectors, has recently appointed Dame Louise Makin, DBE, Ph.D., to its esteemed Board of Directors. With her initial term set to expire at the 2025 Annual Meeting of Stockholders, Dame Louise fills a crucial vacancy on the board, emphasizing Avantor's commitment to maintaining robust leadership.
Dame Louise Makin: A Leader with Vision
Dame Louise brings an impressive breadth of experience to Avantor's Board. As the former Chief Executive Officer of BTG plc, an international healthcare specialist, she played a pivotal role in the company's transformation through strategic growth and acquisitions, culminating in BTG's successful acquisition by Boston Scientific in 2019. Her extensive background also includes various leadership roles at Baxter Healthcare, where she served as the President of Biopharmaceuticals Europe.
Enhanced Board Diversity and Expertise
Jonathan Peacock, Chairman of the Avantor Board, expressed enthusiasm about Dame Louise's appointment, stating, "Dame Louise has a proven track record of success in the life sciences industry, and we are excited to welcome her to the Avantor Board of Directors. Her addition reinforces our commitment to fostering a diverse board with the right mix of skills and experiences essential for driving innovation and creating long-term shareholder value."
A Focus on Strengthening Avantor's Market Position
In her own words, Dame Louise shared her excitement for this new role, saying, "It is an honor to join the Avantor Board of Directors. I look forward to working alongside the board and executive team to fortify the company's position as a leader in life sciences and advanced technologies. Avantor's global reach and innovative offerings uniquely empower it to contribute to every phase of scientific advancement, delivering unparalleled value to its diverse stakeholders."
Looking Ahead with Strong Leadership
Michael Stubblefield, Avantor's President and Chief Executive Officer, welcomed her fresh insights and extensive expertise. He noted, "Dame Louise is an excellent addition to our Board. Her experience will be invaluable as we pursue our strategic plan focused on sustainable growth and increased value for our shareholders."
Dame Louise's Accomplished Background
Currently, Dame Louise is the non-executive chair of Halma plc's Board of Directors and has contributed to the Boards of several companies, including Premier Foods plc, Intertek Group plc, and Atotech Ltd. Notably, she was a Trustee of The Outward Bound Trust for a decade and served as Chair of the 1851 Trust for five years. Furthermore, she has been recognized as an Honorary Fellow of St John's College, Cambridge, and holds both a master's in natural sciences and a Ph.D. in material sciences from the University of Cambridge. In addition, she completed an MBA at The Open University in Milton Keynes, England, and was honored as a Dame Commander of the Order of the British Empire in 2014.
About Avantor
Avantor is a leading life sciences tools company dedicated to providing essential products and services tailored for life sciences and advanced technology industries. By partnering with customers throughout the scientific journey, Avantor empowers breakthroughs in medicine, healthcare, and technology. Their comprehensive portfolio supports critical research, development, and production endeavors at over 300,000 customer locations across 180 countries.
Frequently Asked Questions
1. Who is Dame Louise Makin?
Dame Louise Makin is a seasoned executive with extensive experience in the life sciences sector, previously serving as CEO of BTG plc.
2. What role has she been appointed to at Avantor?
She has been appointed to the Board of Directors of Avantor, with her tenure beginning immediately and set to conclude at the 2025 Annual Meeting of Stockholders.
3. Why is her appointment significant for Avantor?
Her appointment enhances board diversity, reinforces Avantor's strategic vision, and brings valuable expertise to drive growth and innovation.
4. What companies has Dame Louise previously worked with?
Dame Louise has held significant roles in companies like BTG plc, Baxter Healthcare, and has served on several other boards, enhancing her extensive leadership experience.
5. What does Avantor do?
Avantor is recognized for its mission-critical products and services that support customers in the life sciences and advanced technology fields, promoting breakthroughs in various scientific disciplines.
